ClinicalTrials.Veeva

Menu

The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study (TONIC)

U

Universitair Ziekenhuis Brussel

Status

Enrolling

Conditions

Peripheral Blood Mononuclear Cells
Complement Abnormality
Covid19

Treatments

Other: Blood analysis

Study type

Interventional

Funder types

Other

Identifiers

NCT05258643
2020/177

Details and patient eligibility

About

The current study is an open, non-randomized, monocentric, and interventional study. CoViD-19 patients will be recruited at UZ Brussel after informed consent is obtained. Whole blood and serum samples will be collected during acute disease (inclusion and 7 days after inclusion) and during patient follow-up at 2 months after infection.

Sample storage and subsequent use in fundamental research will be performed at VUB Neuro-Aging and Viro-Immunotherapy.

Additionally, medical records of UZ Brussel will be searched and epidemiological, clinical, radiological, and biological data of the selected patients will be obtained at the diagnosis time point and during follow-up.

Healthy volunteers will be recruited as well in the current study, as a comparison arm, after informed consent is obtained.

Enrollment

150 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Covid-19 patients

Inclusion Criteria:

  • Positive nasopharyngeal reverse transcriptase-polymerase chain reaction for SARS-Coronavirus-02
  • Signed inform consent

Healthy Volunteers

Inclusion Criteria:

  • Signed inform consent

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 2 patient groups

Covid-19 patients
Other group
Description:
Whole blood and serum samples will be collected during acute disease (inclusion and 7 days after inclusion) and during patient follow-up at 2 months after infection
Treatment:
Other: Blood analysis
Controle
Other group
Description:
Whole blood and serum samples will be collected during the same period
Treatment:
Other: Blood analysis

Trial contacts and locations

1

Loading...

Central trial contact

Marco Moretti

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems